+1 347 708 0418
The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), with revenue, gross margin and global market share of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) from 2019 to 2021.
Chapter 3, the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Type
1.2.1 Overview: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2020
1.2.3 Paracetamol
1.2.4 Ibuprofen
1.2.5 Aspirin
1.2.6 Naproxen
1.2.7 Others
1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
1.3.1 Overview: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast
1.5 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast by Region
1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region, (2016-2021)
1.5.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)
1.5.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)
1.5.6 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
1.6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
1.6.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.1.4 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.2.4 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.3.4 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Teva Pharmaceutical
2.4.1 Teva Pharmaceutical Details
2.4.2 Teva Pharmaceutical Major Business
2.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.4.4 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Teva Pharmaceutical Recent Developments and Future Plans
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business
2.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.5.4 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hospira Recent Developments and Future Plans
2.6 Lonza Group
2.6.1 Lonza Group Details
2.6.2 Lonza Group Major Business
2.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.6.4 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lonza Group Recent Developments and Future Plans
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.7.4 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Mylan Recent Developments and Future Plans
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.8.4 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Aurobindo Pharma Recent Developments and Future Plans
2.9 Dr. Reddy's Laboratories
2.9.1 Dr. Reddy's Laboratories Details
2.9.2 Dr. Reddy's Laboratories Major Business
2.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.9.4 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
2.10 Actavis
2.10.1 Actavis Details
2.10.2 Actavis Major Business
2.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.10.4 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Actavis Recent Developments and Future Plans
2.11 Wuxi Apptec
2.11.1 Wuxi Apptec Details
2.11.2 Wuxi Apptec Major Business
2.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.11.4 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Wuxi Apptec Recent Developments and Future Plans
2.12 Zhejiang NHU
2.12.1 Zhejiang NHU Details
2.12.2 Zhejiang NHU Major Business
2.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.12.4 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Zhejiang NHU Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.2.2 Top 10 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.2.3 Market Competition Trend
3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2016-2021)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021)
5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)
6.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)
6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.3.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)
6.3.2 United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
6.3.3 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
6.3.4 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)
7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.3.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)
7.3.2 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
7.3.3 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
7.3.5 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
7.3.6 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)
8.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)
8.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
8.3.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2016-2026)
8.3.2 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8.3.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8.3.4 South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8.3.5 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
8.3.7 Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)
9.2 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)
9.3 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
9.3.1 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)
9.3.2 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
9.3.3 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)
10.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)
10.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.3.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)
10.3.2 Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
10.3.4 UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 9. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 13. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim Major Business
Table 16. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 17. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Teva Pharmaceutical Major Business
Table 20. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 21. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Hospira Corporate Information, Head Office, and Major Competitors
Table 23. Hospira Major Business
Table 24. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 25. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Lonza Group Corporate Information, Head Office, and Major Competitors
Table 27. Lonza Group Major Business
Table 28. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 29. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Mylan Corporate Information, Head Office, and Major Competitors
Table 31. Mylan Major Business
Table 32. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 33. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Aurobindo Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Aurobindo Pharma Major Business
Table 36. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 37. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Dr. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors
Table 39. Dr. Reddy's Laboratories Major Business
Table 40. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 41. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Actavis Corporate Information, Head Office, and Major Competitors
Table 43. Actavis Major Business
Table 44. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 45. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Wuxi Apptec Corporate Information, Head Office, and Major Competitors
Table 47. Wuxi Apptec Major Business
Table 48. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 49. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Zhejiang NHU Corporate Information, Head Office, and Major Competitors
Table 51. Zhejiang NHU Major Business
Table 52. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 53. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Players (2019-2021)
Table 55. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2019-2021)
Table 56. Breakdown of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided
Table 58. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Mergers & Acquisitions in the Past Five Years
Table 59. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) New Entrants and Expansion Plans
Table 60. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Type (2016-2021)
Table 61. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2016-2021)
Table 62. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2021-2026)
Table 63. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021)
Table 64. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2021-2026)
Table 65. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2020
Figure 3. Paracetamol
Figure 4. Ibuprofen
Figure 5. Aspirin
Figure 6. Naproxen
Figure 7. Others
Figure 8. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application in 2020
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2016-2026)
Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region in 2020
Figure 16. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Figure 22. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Figure 23. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Boehringer Ingelheim Recent Developments and Future Plans
Figure 27. Teva Pharmaceutical Recent Developments and Future Plans
Figure 28. Hospira Recent Developments and Future Plans
Figure 29. Lonza Group Recent Developments and Future Plans
Figure 30. Mylan Recent Developments and Future Plans
Figure 31. Aurobindo Pharma Recent Developments and Future Plans
Figure 32. Dr. Reddy's Laboratories Recent Developments and Future Plans
Figure 33. Actavis Recent Developments and Future Plans
Figure 34. Wuxi Apptec Recent Developments and Future Plans
Figure 35. Zhejiang NHU Recent Developments and Future Plans
Figure 36. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2020
Figure 37. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2020
Figure 39. Global Top 10 Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type in 2020
Figure 42. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2021-2026)
Figure 43. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application in 2020
Figure 44. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2021-2026)
Figure 45. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)
Figure 46. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)
Figure 47. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)
Figure 48. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)
Figure 52. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)
Figure 53. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)
Figure 54. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2016-2026)
Figure 62. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)
Figure 69. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)
Figure 70. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Buy
